Pasar al contenido principal

Resultados de investigación

Rights
Projectcode
Resultados totales (Incluyendo duplicados): 81720
Encontrada(s) 8172 página(s)
DIGITAL.CSIC. Repositorio Institucional del CSIC
oai:digital.csic.es:10261/366961
Datos de investigación Set de datos (Dataset)

Supplementary Data S1 from Biomarkers of Efficacy and Safety of the Academic BCMA-CART ARI0002h for the Treatment of Refractory Multiple Myeloma [Dataset]

  • Oliver-Caldés, Aina
  • Español-Rego, Marta
  • Zabaleta, Aintzane
  • González-Calle, Verónica
  • Navarro-Velázquez, Sergio
  • Inogés, Susana
  • López-Díaz de Cerio, Ascensión
  • Cabañas, Valentín
  • López-Muñoz, Nieves
  • Rodríguez-Otero, Paula
  • Reguera-Ortega, Juan Luis
  • Moreno, David F.
  • Martínez-Cibrián, Nuria
  • López-Corral, Lucía
  • Pérez-Amill, Lorena
  • Martin-Antonio, Beatriz
  • Rosiñol, Laura
  • Cid, Joan
  • Tovar, Natalia
  • Sáez-Peñataro, Joaquín
  • López-Parra, Miriam
  • Olesti, Eulalia
  • Guillén, Elena
  • Varea, Sara
  • Rodríguez-Lobato, Luis Gerardo
  • Battram, Anthony M.
  • González, Marta Sonia
  • Sánchez-Salinas, Andrés
  • González-Navarro, Azucena
  • Ortiz-Maldonado, Valentín
  • Delgado, Julio
  • Prósper, Felipe
  • Juan, Manel
  • Martínez-López, Joaquín
  • Moraleda, José María
  • Mateos, Maria Victoria
  • Urbano-Ispizúa, Álvaro
  • Paiva, Bruno
  • Pascal, Mariona
  • Fernández de Larrea, Carlos
B-cell maturation antigen (BCMA)-chimeric antigen receptor T-cells (CART) improve results obtained with conventional therapy in the treatment of relapsed/refractory multiple myeloma. However, the high demand and expensive costs associated with CART therapy might prove unsustainable for health systems. Academic CARTs could potentially overcome these issues. Moreover, response biomarkers and resistance mechanisms need to be identified and addressed to improve efficacy and patient selection. Here, we present clinical and ancillary results of the 60 patients treated with the academic BCMA-CART, ARI0002h, in the CARTBCMA-HCB-01 trial. We collected apheresis, final product, peripheral blood and bone marrow samples before and after infusion. We assessed BCMA, T-cell subsets, CART kinetics and antibodies, B-cell aplasia, cytokines, and measurable residual disease by next-generation flow cytometry, and correlated these to clinical outcomes. At cut-off date March 17, 2023, with a median follow-up of 23.1 months (95% CI, 9.2–37.1), overall response rate in the first 3 months was 95% [95% confidence interval (CI), 89.5–100]; cytokine release syndrome (CRS) was observed in 90% of patients (5% grades ≥3) and grade 1 immune effector cell-associated neurotoxicity syndrome was reported in 2 patients (3%). Median progression-free survival was 15.8 months (95% CI, 11.5–22.4). Surface BCMA was not predictive of response or survival, but soluble BCMA correlated with worse clinical outcomes and CRS severity. Activation marker HLA-DR in the apheresis was associated with longer progression-free survival and increased exhaustion markers correlated with poorer outcomes. ARI0002h kinetics and loss of B-cell aplasia were not predictive of relapse. Despite deep and sustained responses achieved with ARI0002h, we identified several biomarkers that correlate with poor outcomes., Instituto de Salud Carlos III (ISCIII) 'la Caixa' Foundation ('la Caixa') Fundación Científica Asociación Española Contra el Cáncer (AECC), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
oai:digital.csic.es:10261/366962
Datos de investigación Set de datos (Dataset)

Supplementary Figure S1 from Biomarkers of Efficacy and Safety of the Academic BCMA-CART ARI0002h for the Treatment of Refractory Multiple Myeloma [Dataset]

  • Oliver-Caldés, Aina
  • Español-Rego, Marta
  • Zabaleta, Aintzane
  • González-Calle, Verónica
  • Navarro-Velázquez, Sergio
  • Inogés, Susana
  • López-Díaz de Cerio, Ascensión
  • Cabañas, Valentín
  • López-Muñoz, Nieves
  • Rodríguez-Otero, Paula
  • Reguera-Ortega, Juan Luis
  • Moreno, David F.
  • Martínez-Cibrián, Nuria
  • López-Corral, Lucía
  • Pérez-Amill, Lorena
  • Martin-Antonio, Beatriz
  • Rosiñol, Laura
  • Cid, Joan
  • Tovar, Natalia
  • Sáez-Peñataro, Joaquín
  • López-Parra, Miriam
  • Olesti, Eulalia
  • Guillén, Elena
  • Varea, Sara
  • Rodríguez-Lobato, Luis Gerardo
  • Battram, Anthony M.
  • González, Marta Sonia
  • Sánchez-Salinas, Andrés
  • González-Navarro, Azucena
  • Ortiz-Maldonado, Valentín
  • Delgado, Julio
  • Prósper, Felipe
  • Juan, Manel
  • Martínez-López, Joaquín
  • Moraleda, José María
  • Mateos, Maria Victoria
  • Urbano-Ispizúa, Álvaro
  • Paiva, Bruno
  • Pascal, Mariona
  • Fernández de Larrea, Carlos
B-cell maturation antigen (BCMA)-chimeric antigen receptor T-cells (CART) improve results obtained with conventional therapy in the treatment of relapsed/refractory multiple myeloma. However, the high demand and expensive costs associated with CART therapy might prove unsustainable for health systems. Academic CARTs could potentially overcome these issues. Moreover, response biomarkers and resistance mechanisms need to be identified and addressed to improve efficacy and patient selection. Here, we present clinical and ancillary results of the 60 patients treated with the academic BCMA-CART, ARI0002h, in the CARTBCMA-HCB-01 trial. We collected apheresis, final product, peripheral blood and bone marrow samples before and after infusion. We assessed BCMA, T-cell subsets, CART kinetics and antibodies, B-cell aplasia, cytokines, and measurable residual disease by next-generation flow cytometry, and correlated these to clinical outcomes. At cut-off date March 17, 2023, with a median follow-up of 23.1 months (95% CI, 9.2–37.1), overall response rate in the first 3 months was 95% [95% confidence interval (CI), 89.5–100]; cytokine release syndrome (CRS) was observed in 90% of patients (5% grades ≥3) and grade 1 immune effector cell-associated neurotoxicity syndrome was reported in 2 patients (3%). Median progression-free survival was 15.8 months (95% CI, 11.5–22.4). Surface BCMA was not predictive of response or survival, but soluble BCMA correlated with worse clinical outcomes and CRS severity. Activation marker HLA-DR in the apheresis was associated with longer progression-free survival and increased exhaustion markers correlated with poorer outcomes. ARI0002h kinetics and loss of B-cell aplasia were not predictive of relapse. Despite deep and sustained responses achieved with ARI0002h, we identified several biomarkers that correlate with poor outcomes., Instituto de Salud Carlos III (ISCIII) 'la Caixa' Foundation ('la Caixa') Fundación Científica Asociación Española Contra el Cáncer (AECC), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
oai:digital.csic.es:10261/366963
Datos de investigación Set de datos (Dataset)

Supplementary Figure S10 from Biomarkers of Efficacy and Safety of the Academic BCMA-CART ARI0002h for the Treatment of Refractory Multiple Myeloma [Dataset]

  • Oliver-Caldés, Aina
  • Español-Rego, Marta
  • Zabaleta, Aintzane
  • González-Calle, Verónica
  • Navarro-Velázquez, Sergio
  • Inogés, Susana
  • López-Díaz de Cerio, Ascensión
  • Cabañas, Valentín
  • López-Muñoz, Nieves
  • Rodríguez-Otero, Paula
  • Reguera-Ortega, Juan Luis
  • Moreno, David F.
  • Martínez-Cibrián, Nuria
  • López-Corral, Lucía
  • Pérez-Amill, Lorena
  • Martin-Antonio, Beatriz
  • Rosiñol, Laura
  • Cid, Joan
  • Tovar, Natalia
  • Sáez-Peñataro, Joaquín
  • Olesti, Eulalia
  • Guillén, Elena
  • Varea, Sara
  • Rodríguez-Lobato, Luis Gerardo
  • Battram, Anthony M.
  • González, Marta Sonia
  • Sánchez-Salinas, Andrés
  • González-Navarro, Azucena
  • Ortiz-Maldonado, Valentín
  • Delgado, Julio
  • Prósper, Felipe
  • Juan, Manel
  • Martínez-López, Joaquín
  • Moraleda, José María
  • Mateos, Maria Victoria
  • Urbano-Ispizúa, Álvaro
  • Paiva, Bruno
  • Pascal, Mariona
  • Fernández de Larrea, Carlos
B-cell maturation antigen (BCMA)-chimeric antigen receptor T-cells (CART) improve results obtained with conventional therapy in the treatment of relapsed/refractory multiple myeloma. However, the high demand and expensive costs associated with CART therapy might prove unsustainable for health systems. Academic CARTs could potentially overcome these issues. Moreover, response biomarkers and resistance mechanisms need to be identified and addressed to improve efficacy and patient selection. Here, we present clinical and ancillary results of the 60 patients treated with the academic BCMA-CART, ARI0002h, in the CARTBCMA-HCB-01 trial. We collected apheresis, final product, peripheral blood and bone marrow samples before and after infusion. We assessed BCMA, T-cell subsets, CART kinetics and antibodies, B-cell aplasia, cytokines, and measurable residual disease by next-generation flow cytometry, and correlated these to clinical outcomes. At cut-off date March 17, 2023, with a median follow-up of 23.1 months (95% CI, 9.2–37.1), overall response rate in the first 3 months was 95% [95% confidence interval (CI), 89.5–100]; cytokine release syndrome (CRS) was observed in 90% of patients (5% grades ≥3) and grade 1 immune effector cell-associated neurotoxicity syndrome was reported in 2 patients (3%). Median progression-free survival was 15.8 months (95% CI, 11.5–22.4). Surface BCMA was not predictive of response or survival, but soluble BCMA correlated with worse clinical outcomes and CRS severity. Activation marker HLA-DR in the apheresis was associated with longer progression-free survival and increased exhaustion markers correlated with poorer outcomes. ARI0002h kinetics and loss of B-cell aplasia were not predictive of relapse. Despite deep and sustained responses achieved with ARI0002h, we identified several biomarkers that correlate with poor outcomes., Instituto de Salud Carlos III (ISCIII) 'la Caixa' Foundation ('la Caixa') Fundación Científica Asociación Española Contra el Cáncer (AECC), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
oai:digital.csic.es:10261/367444
Datos de investigación Set de datos (Dataset)

Compilation of locations, larval durations and dates of spawning and settlement for coastal fishes in the Mediterranean Sea

  • Di Stefano, Marine
  • Nerini, David
  • Álvarez-Ellacuria, Itziar
  • Ardizzone, Giandomenico
  • Astruch, Patrick
  • Basterretxea, Gotzon
  • Blanfuné, Aurélie
  • Bonhomme, Denis
  • Calò, Antonio
  • Catalán, Ignacio Alberto
  • Cattano, Carlo
  • Cheminée, Adrien
  • Crec'hriou, Romain
  • Cuadros, Amalia
  • Cuadros, Amalia
  • Díaz-Gil, Carlos
  • Estaque, Tristan
  • Faillettaz, Robin
  • Félix-Hackradt, Fabiana C.
  • García-Charton, José A.
  • Guidetti, Paolo
  • Guilloux, Loïc
  • Harmelin, Jean Georges
  • Harmelin-Vivien, Mireille
  • Hidalgo, Manuel
  • Hinz, Hilmar
  • Irisson, Jean-Olivier
  • La Mesa, Gabriele
  • Le Diréach, Laurence
  • Lenfant, Philippe
  • Macpherson, Enrique
  • Matić-Skoko, Sanja
  • Mercader, Manon
  • Milazzo, Marco
  • Monfort, Tiffany
  • Moranta, Joan
  • Muntoni, Manuel
  • Murenu, Matteo
  • Nunez, Lucie
  • Olivar, M. Pilar
  • Pastor, Jérémy
  • Pérez-Ruzafa, Ángel
  • Planes, Serge
  • Raventós, Núria
  • Richaume, Justine
  • Rouanet, Elodie
  • Roussel, Erwan
  • Ruitton, Sandrine
  • Sabatés, Ana
  • Thibaut, Thierry
  • Ventura, Daniele
  • Vigliola, Laurent
  • Vrdoljak, Dario
  • Rossi, Vincent
Location: 46.283801N, 34.810924S, 22.137451E, -6.514893W, Early-life stages play a key role in the spatio-temporal dynamics of marine populations due to their highly dispersive properties, their sensitivities to environmental factors and their influences on juveniles’ replenishment. However, these stages are difficult to monitor, so that in-situ observations are scarce and disparate, preventing a good understanding of the control they exert on population dynamics. The Mediterranean coastlines have been highly surveyed during the last decades in different sub-regions; yet no effort was made to assemble observations originating from different research projects and countries. Moreover, this sea has been exploited for centuries and is now recognized as a climate-change hotspot, so that it represents an ideal laboratory to address the role of anthropogenic pressures on marine populations. To advance our knowledge, we build an exhaustive compilation of historical data collected over the past decades up to present. From spawning to settlement, it evaluates both egg and larval stages of coastal fishes characterized by bipartite life cycles. This compilation gathers 44 datasets from North-Western Mediterranean countries (including coastlines of Spain, France, Italy, Croatia and Montenegro) over the last three decades (1993-2021) originating from 48 data providers. We consider direct and indirect observations of early-life stages such as otoliths’ data, datasets of settlers and juveniles sampled by underwater visual census, shore seine, hand-nets or light-traps, as well as fish eggs and larvae sampled with plankton nets. All those types of data are harmonized into a uniform dataset that informs on the periods and locations of spawning and settlement. While some sampling techniques directly provide the variables of interests, other methods require a-posteriori estimations based on growth models from the Dynamic Energy Budget (DEB) theory, using taxon-dependent parameters available in the online Add-my-Pet database. Finally, the complete database consists in several taxon, each of them being associated with dates of both spawning and settlement, as well as other information such as the pelagic larval duration, measures of uncertainties and sampling characteristics (location, depth, etc). Statistical analyses of the consolidated database describe the overall coverage of sampling and evaluate the sampling gaps over space and time in order to guide future sampling efforts. In fact, sampling mainly occurs around marine reserves and from May to October. The general coverage of spawning and settlement is then assessed, looking at the differences between observed data (same distribution as sampling) and back-calculated data (nearly uniformly distributed over the year). Moreover, the overall taxa distribution is described, mainly represented by Sparidae. Thus, this database informs early-life traits and their variability for different coastal fish taxa in the North-Western Mediterranean in order to document their evolution in a changing world. Indeed, this database will be publicly available to help undertake future connectivity and climatic studies., The authors acknowledge support from Région Sud for M.D.S.'s PhD grant and co-funding by Port-Cros National Park through a project supported by the Prince Albert II of Monaco Foundation., With the institutional support of the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2019-000928-S)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
oai:digital.csic.es:10261/367496
Datos de investigación Set de datos (Dataset)

Entrevista (grabación y transcripción traducida parcial) a Coman Lupu

  • Ilian, Ilinca
  • ELASOC
Esta publicación es parte del proyecto de I+D+i Escritores latinoamericanos en los países socialistas europeos durante la Guerra Fría (PID2020-113994GB-I00), financiado por MCIN/ AEI/10.13039/501100011033/., Este conjunto de datos contiene una entrevista en rumano realizada al traductor rumano Coman Lupu por la profesora Ilinca Ilian en 2015. Se presenta en 3 archivos de audio. Así mismo, contiene una transcripción parcial de la entrevista, traducida al español, y realizada en febrero de 2024, dentro del proyecto ELASOC. La transcripción se presenta en un archivo pdf, Esta publicación es parte del proyecto de I+D+i Escritores latinoamericanos en los países socialistas europeos durante la Guerra Fría (PID2020-113994GB-I00), financiado por MCIN/ AEI/10.13039/501100011033/., No
DIGITAL.CSIC. Repositorio Institucional del CSIC
oai:digital.csic.es:10261/367569
Datos de investigación Set de datos (Dataset)

Additional file 1 of Comparative 3D genome analysis between neural retina and retinal pigment epithelium reveals differential cis-regulatory interactions at retinal disease loci [Dataset]

  • D’haene, Eva
  • López Soriano, Víctor
  • Martínez-García, Pedro Manuel
  • Kalayanamontri, Soraya
  • Dueñas Rey, Alfredo
  • Sousa Ortega, Ana
  • Naranjo, Silvia
  • Sompele, Stijn Van de
  • Vantomme, Lies
  • Mahieu, Quinten
  • Vergult, Sarah
  • Neto, Ana
  • Gómez-Skarmeta, José Luis
  • Martínez-Morales, Juan Ramón
  • Bauwens, Miriam
  • Tena, Juan J.
  • Baere, Elfride De
Additional file 1. Supplementary Figures S1-22 (.pdf)., Ghent University Special Research Fund H2020 Marie Skłodowska-Curie Actions European Joint Programme on Rare Diseases (EJP RD) Research Foundation Flanders (FWO) Foundation John W. Mouton Pro Retina & Marie-Claire Liénaert Ghent University Fund Alzheimer and Neurodegenerative Diseases Junta de Andalucía, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
oai:digital.csic.es:10261/367596
Datos de investigación Set de datos (Dataset)

Additional file 3 of Comparative 3D genome analysis between neural retina and retinal pigment epithelium reveals differential cis-regulatory interactions at retinal disease loci [Dataset]

  • D’haene, Eva
  • López Soriano, Víctor
  • Martínez-García, Pedro Manuel
  • Kalayanamontri, Soraya
  • Dueñas Rey, Alfredo
  • Sousa Ortega, Ana
  • Naranjo, Silvia
  • Sompele, Stijn Van de
  • Vantomme, Lies
  • Mahieu, Quinten
  • Vergult, Sarah
  • Neto, Ana
  • Gómez-Skarmeta, José Luis
  • Martínez-Morales, Juan Ramón
  • Bauwens, Miriam
  • Tena, Juan J.
  • Baere, Elfride De
Additional file 3. BED file with Hi-C boundaries in RPE/choroid (25 kb resolution)., Ghent University European Commission Research Foundation - Flanders Junta de Andalucía, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
oai:digital.csic.es:10261/367608
Datos de investigación Set de datos (Dataset)

Supplement of Early-life dispersal traits of coastal fishes: an extensive database combining observations and growth models

  • Di Stefano, Marine
  • Nerini, David
  • Álvarez, Itziar
  • Ardizzone, Giandomenico
  • Astruch, Patrick
  • Basterretxea, Gotzon
  • Blanfuné, Aurélie
  • Bonhomme, Denis
  • Calò, Antonio
  • Catalán, Ignacio Alberto
  • Cattano, Carlo
  • Cheminée, Adrien
  • Crec'hriou, Romain
  • Cuadros, Amalia
  • Di Franco, Antonio
  • Díaz-Gil, Carlos
  • Estaque, Tristan
  • Faillettaz, Robin
  • Félix-Hackradt, Fabiana C.
  • García-Charton, José A.
  • Guidetti, Paolo
  • Guilloux, Loïc
  • Harmelin, Jean Georges
  • Harmelin-Vivien, Mireille
  • Hidalgo, Manuel
  • Hinz, Hilmar
  • Irisson, Jean-Olivier
  • La Mesa, Gabriele
  • Le Diréach, Laurence
  • Lenfant, Philippe
  • Macpherson, Enrique
  • Matić-Skoko, Sanja
  • Mercader, Manon
  • Milazzo, Marco
  • Monfort, Tiffany
  • Moranta, Joan
  • Muntoni, Manuel
  • Murenu, Matteo
  • Nunez, Lucie
  • Olivar, M. Pilar
  • Pastor, Jérémy
  • Pérez-Ruzafa, Ángel
  • Planes, Serge
  • Raventós, Núria
  • Richaume, Justine
  • Rouanet, Elodie
  • Roussel, Erwan
  • Ruitton, Sandrine
  • Sabatés, Ana
  • Thibaut, Thierry
  • Ventura, Daniele
  • Vigliola, Laurent
  • Vrdoljak, Dario
  • Rossi, Vincent
16 páginas con 7 figuras, 6 tablas y bibliografía., With the institutional support of the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2019-000928-S)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
oai:digital.csic.es:10261/367611
Datos de investigación Set de datos (Dataset)

Additional file 4 of Comparative 3D genome analysis between neural retina and retinal pigment epithelium reveals differential cis-regulatory interactions at retinal disease loci [Dataset]

  • D’haene, Eva
  • López Soriano, Víctor
  • Martínez-García, Pedro Manuel
  • Kalayanamontri, Soraya
  • Dueñas Rey, Alfredo
  • Sousa Ortega, Ana
  • Naranjo, Silvia
  • Sompele, Stijn Van de
  • Vantomme, Lies
  • Mahieu, Quinten
  • Vergult, Sarah
  • Neto, Ana
  • Gómez-Skarmeta, José Luis
  • Martínez-Morales, Juan Ramón
  • Bauwens, Miriam
  • Tena, Juan J.
  • Baere, Elfride De
Additional file 4. BED file with Hi-C CHESS regions with differential 3D topology between neural retina vs. RPE/choroid., Ghent University European Commission Research Foundation - Flanders Junta de Andalucía, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
oai:digital.csic.es:10261/367616
Datos de investigación Set de datos (Dataset)

Additional file 5 of Comparative 3D genome analysis between neural retina and retinal pigment epithelium reveals differential cis-regulatory interactions at retinal disease loci [Dataset]

  • D’haene, Eva
  • López Soriano, Víctor
  • Martínez-García, Pedro Manuel
  • Kalayanamontri, Soraya
  • Dueñas Rey, Alfredo
  • Sousa Ortega, Ana
  • Naranjo, Silvia
  • Sompele, Stijn Van de
  • Vantomme, Lies
  • Mahieu, Quinten
  • Vergult, Sarah
  • Neto, Ana
  • Gómez-Skarmeta, José Luis
  • Martínez-Morales, Juan Ramón
  • Bauwens, Miriam
  • Tena, Juan J.
  • Baere, Elfride De
Additional file 5. BEDPE file with Hi-C loops in neural retina., Ghent University European Commission Research Foundation - Flanders Junta de Andalucía, Peer reviewed
Buscador avanzado